Antiseizure medications and challenges in the COVID-19 pandemic – focus on drug interactions
Thursday, 3-5 pm CET
9 April 2020
During the COVID19 pandemic crisis we receive a number of questions on anti-seizure drug interactions.
The ERN EpiCARE working group on Education and Training invited a panel of experts in Clinical Pharmacology and/or on Treatment of Status Epilepticus, and members of EpiCARE, to share their experience on this very challenging topic.
Members of the panel
Professor Cecilie Landmark (Oslo, NORWAY)
Professor Emilio Perucca (Pavia, ITALY)
Professor Eugen Trinka(Salzburg, AUSTRIA)
Professor Simon Shorvon (London, UK)
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community